Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Zepbound (semaglutide) follows a 16-week titration schedule that gradually increases your dose every four weeks to minimize side effects and help your body adapt. Once you reach your target dose—typically called your "maintenance dose"—you stay on that level as long as you're meeting your health goals. Understanding what maintenance means and how to know when you've arrived there helps you feel confident in your weight loss treatment.

Understanding Zepbound Maintenance Dosing

Maintenance dose refers to the weekly injection strength you take consistently after the initial titration phase ends. Unlike the ramp-up period where doses change monthly, maintenance is stable—the dose you've reached is the one your body uses to suppress appetite and improve metabolic function. Zepbound maintenance doses typically range from 1.7 mg to 2.4 mg weekly, with most patients settling at 2.4 mg based on clinical trial data.

Your maintenance dose isn't one-size-fits-all. Some people reach their weight loss target at 1.7 mg weekly and feel satisfied staying there; others need the full 2.4 mg dose to achieve meaningful results. PlexusDx works with you to find the dose that balances efficacy with tolerability, so you stay consistent with treatment rather than stopping due to side effects or dissatisfaction.

The Typical Zepbound Dose Escalation Timeline

Zepbound uses a four-step titration designed to help your body adapt gradually. Week one through four: 0.25 mg dose. Weeks five through eight: 0.5 mg dose. Weeks nine through twelve: 1 mg dose. Weeks thirteen through sixteen: 2 mg dose. After week 16, many patients move to 2.4 mg for ongoing maintenance. This staggered approach reduces nausea and gastrointestinal upset that can occur when doses jump too quickly.

Some people feel their appetite suppression and weight loss plateauing before reaching the highest tier. If that happens, your healthcare provider may keep you at a lower maintenance dose—say, 1.7 mg or 2 mg—rather than pushing to 2.4 mg. The goal is sustainable weight management, not chasing a number on a scale at the expense of quality of life.

How to Know You've Found Your Maintenance Dose

You've reached your maintenance dose when you experience steady appetite suppression, stable weight loss over two to four weeks, and manageable side effects. Some signs include consistent reduction in hunger between meals, decreased cravings for high-calorie foods, and gradual weight decline without rapid fluctuations. If you're still losing weight quickly and tolerating the dose well, your provider might continue the titration; if side effects are limiting quality of life, stepping back one tier is an option.

Maintenance isn't forever static either. As your body composition changes and you lose weight, your provider may adjust your dose downward to maintain results without unnecessary medication exposure. PlexusDx's personalized approach means your maintenance plan gets revisited regularly—every 4 to 12 weeks—to keep pace with your changing physiology and goals.

Personalizing Your Maintenance Dose with Genetic Insight

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Zepbound or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Key genetic variants like GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 influence how your body's hunger and satiety signals respond to medication. By understanding your genetic profile from month one, PlexusDx can suggest a starting dose tier and maintenance target tailored to your individual biology, reducing trial-and-error and helping you reach your ideal dose faster with fewer adjustments.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is 2.4 mg the only maintenance dose for Zepbound?

No. While 2.4 mg is the highest dose in the standard titration and works well for many patients, maintenance doses range from 1.7 mg to 2.4 mg depending on your weight loss goals, tolerability, and body's response. Your healthcare provider helps determine the right maintenance level for you based on results and side effects.

How long does the Zepbound titration phase last?

The standard titration is 16 weeks, with doses increasing every four weeks (0.25 mg → 0.5 mg → 1 mg → 2 mg). After week 16, most patients move to 2.4 mg maintenance, though some stabilize at lower doses. If you experience side effects, titration can be slowed down with your provider's guidance.

Can I stay on a lower Zepbound dose long-term if it's working?

Yes. If you're reaching your weight loss targets and feeling well on 1.7 mg or 2 mg weekly, staying at that dose as your maintenance level is appropriate. PlexusDx and your provider monitor your progress regularly to confirm the dose is still meeting your needs without unnecessary escalation.

What happens if Zepbound side effects are too much at my maintenance dose?

If nausea, vomiting, or other side effects limit your quality of life, your provider can reduce your dose to a lower maintenance tier—such as stepping back from 2.4 mg to 2 mg. Dietary adjustments and slower eating also help. PlexusDx compounded tirzepatide injection offers an alternative if semaglutide isn't well tolerated.

How does PlexusDx help optimize my maintenance dose?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves